These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31326791)

  • 1. Maternally expressed gene 3 (MEG3): A tumor suppressor long non coding RNA.
    Ghafouri-Fard S; Taheri M
    Biomed Pharmacother; 2019 Oct; 118():109129. PubMed ID: 31326791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of long non-coding RNA MEG3 in nasopharyngeal carcinoma.
    Chak WP; Lung RW; Tong JH; Chan SY; Lun SW; Tsao SW; Lo KW; To KF
    Mol Carcinog; 2017 Mar; 56(3):1041-1054. PubMed ID: 27597634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing long non-coding RNA MEG3 accelerates tibia fraction healing by regulating the Wnt/β-catenin signalling pathway.
    Liu YB; Lin LP; Zou R; Zhao QH; Lin FQ
    J Cell Mol Med; 2019 Jun; 23(6):3855-3866. PubMed ID: 30955246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
    Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
    Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.
    Al-Rugeebah A; Alanazi M; Parine NR
    Pathol Oncol Res; 2019 Jul; 25(3):859-874. PubMed ID: 30793226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma.
    Guo W; Dong Z; Liu S; Qiao Y; Kuang G; Guo Y; Shen S; Liang J
    Mol Carcinog; 2017 Aug; 56(8):1924-1934. PubMed ID: 28345805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway.
    Gao Y; Lu X
    Tumour Biol; 2016 Feb; 37(2):1461-9. PubMed ID: 26662307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.
    Xia Y; He Z; Liu B; Wang P; Chen Y
    Mol Med Rep; 2015 Sep; 12(3):4530-4537. PubMed ID: 26059239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA MEG3 promotes the proliferation of glioma cells through targeting Wnt/β-catenin signal pathway.
    Gong X; Huang M
    Cancer Gene Ther; 2017 Sep; 24(9):381-385. PubMed ID: 29027534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer.
    Bayarmaa B; Wu Z; Peng J; Wang Y; Xu S; Yan T; Yin W; Lu J; Zhou L
    BMC Cancer; 2019 Sep; 19(1):877. PubMed ID: 31488093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway.
    Kruer TL; Dougherty SM; Reynolds L; Long E; de Silva T; Lockwood WW; Clem BF
    PLoS One; 2016; 11(11):e0166363. PubMed ID: 27832204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
    PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer.
    Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W
    Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells.
    Zhu J; Liu S; Ye F; Shen Y; Tie Y; Zhu J; Wei L; Jin Y; Fu H; Wu Y; Zheng X
    PLoS One; 2015; 10(10):e0139790. PubMed ID: 26444285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor protects bone marrow mesenchymal stem cells from hypoxia/ischemia-induced apoptosis by regulating lncRNA MEG3.
    Bai Z; Hu K; Yu J; Shen Y; Chen C
    J Zhejiang Univ Sci B; 2022 Dec; 23(12):989-1001. PubMed ID: 36518052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
    Modali SD; Parekh VI; Kebebew E; Agarwal SK
    Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Contribution of Long Non-coding RNA
    Pei JS; Chang WS; Chen CC; Mong MC; Hsu SW; Hsu PC; Hsu YN; Wang YC; Tsai CW; Bau DT
    Cancer Genomics Proteomics; 2022; 19(1):27-34. PubMed ID: 34949657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNMT1-mediated demethylation of lncRNA MEG3 promoter suppressed breast cancer progression by repressing Notch1 signaling pathway.
    Pan T; Ding H; Jin L; Zhang S; Wu D; Pan W; Dong M; Ma X; Chen Z
    Cell Cycle; 2022 Nov; 21(21):2323-2337. PubMed ID: 35822955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of lncRNA MEG3 promotes chronic low dose cadmium exposure-induced cell transformation and cancer stem cell-like property.
    Lin HP; Rea M; Wang Z; Yang C
    Toxicol Appl Pharmacol; 2021 Nov; 430():115724. PubMed ID: 34520792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.